• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

权衡公平与效率:方法学范围综述

Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review.

机构信息

Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA; Susan B. Meister Child Health Evaluation and Research Center, Department of Pediatrics, Medical School, University of Michigan, Ann Arbor, MI, USA.

出版信息

Value Health. 2023 Jun;26(6):943-952. doi: 10.1016/j.jval.2023.02.006. Epub 2023 Feb 18.

DOI:10.1016/j.jval.2023.02.006
PMID:36805575
Abstract

OBJECTIVES

To identify differences in the approaches and results of studies that elicit equity-efficiency trade-offs that can inform equity-informative cost-effectiveness analysis for healthcare resource allocation.

METHODS

We searched Ovid (Medline), EconLit, and Scopus prior to June 25, 2021. Inclusion criteria were: (1) peer-reviewed or (2) gray literature; (3) published in English; (4) survey-based; (5) parameterized a social welfare function to quantify inequality aversion or (6) elicited a trade-off in equity and efficiency characteristics of health interventions. Exclusion criteria were: (1) studies that did not conduct a trade-off or (2) theoretical studies. We abstracted details on study methods, results, and limitations. Studies were grouped by following approach: (1) social welfare function or (2) preference ranking and distributional weighting. We described findings separately for each approach category.

RESULTS

Seventy-seven papers were included, 28 parameterized social welfare functions and 49 were classified as preference ranking and distributional weighting. Study methods were heterogeneous. Studies were conducted across 29 countries. Sample sizes and composition, survey methods and question framing varied. Preferences for equity were mixed. Across both approach categories: 39 studies were classified as clear evidence of inequality aversion; 33 found mixed evidence; and 4 had no evidence of aversion. Evidence of between and within-study heterogeneity was found. Preferences for equity may differ by gender, profession, political ideology, income, and education.

CONCLUSIONS

Substantial variability in study methods limit the direct comparability of findings and their use in equity-informed cost-effectiveness analysis. Future researches using representative samples that explore within and between country heterogeneity is needed.

摘要

目的

识别在引出公平-效率权衡的研究方法和结果方面的差异,为医疗资源配置的公平信息成本效益分析提供信息。

方法

我们在 2021 年 6 月 25 日之前在 Ovid(Medline)、EconLit 和 Scopus 进行了检索。纳入标准为:(1)同行评议或(2)灰色文献;(3)以英文发表;(4)基于调查;(5)参数化社会福利函数以量化不平等厌恶程度,或(6)引出健康干预措施的公平和效率特征的权衡。排除标准为:(1)未进行权衡的研究,或(2)理论研究。我们提取了研究方法、结果和局限性的详细信息。研究按以下方法分组:(1)社会福利函数或(2)偏好排序和分布加权。我们分别描述了每种方法类别的发现。

结果

共纳入 77 篇论文,其中 28 篇参数化了社会福利函数,49 篇被归类为偏好排序和分布加权。研究方法具有异质性。研究在 29 个国家进行。样本量和组成、调查方法和问题框架各不相同。对公平的偏好存在差异。在这两种方法类别中:39 项研究被归类为明显的不平等厌恶证据;33 项研究发现证据混合;4 项研究没有厌恶证据。发现了研究内和研究间的异质性证据。对公平的偏好可能因性别、职业、政治意识形态、收入和教育程度而异。

结论

研究方法的大量差异限制了研究结果的直接可比性及其在公平信息成本效益分析中的应用。需要使用具有代表性的样本进行未来研究,以探索国家内部和国家之间的异质性。

相似文献

1
Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review.权衡公平与效率:方法学范围综述
Value Health. 2023 Jun;26(6):943-952. doi: 10.1016/j.jval.2023.02.006. Epub 2023 Feb 18.
2
Incorporating Equity Concerns in Cost-Effectiveness Analyses: A Systematic Literature Review.将公平性问题纳入成本效益分析中:系统文献回顾。
Pharmacoeconomics. 2022 Jan;40(1):45-64. doi: 10.1007/s40273-021-01094-7. Epub 2021 Oct 29.
3
Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.非小细胞肺癌治疗的分布成本效益分析:综合分析及其关键驱动因素的说明。
Pharmacoeconomics. 2023 Aug;41(8):1011-1025. doi: 10.1007/s40273-023-01281-8. Epub 2023 Jun 9.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
How Much Does the US Public Value Equity in Health? A Systematic Review.美国公众对健康公平的重视程度如何?一项系统评价。
Value Health. 2023 Mar;26(3):418-426. doi: 10.1016/j.jval.2022.08.009. Epub 2022 Oct 8.
6
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.超越黑木树:影响澳大利亚地区、农村和偏远地区的健康研究问题的快速综述。
Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881.
7
Challenges and Limitations in Distributional Cost-Effectiveness Analysis: A Systematic Literature Review.分布成本效益分析中的挑战与局限:系统文献回顾。
Int J Environ Res Public Health. 2022 Dec 28;20(1):505. doi: 10.3390/ijerph20010505.
8
Aversion to geographic inequality and geographic variation in preferences in the context of healthcare.在医疗保健背景下对地理不平等和偏好的地理差异的厌恶。
Appl Health Econ Health Policy. 2009;7(2):121-36. doi: 10.1007/BF03256146.
9
Eliciting public preferences for healthcare: a systematic review of techniques.获取公众对医疗保健的偏好:技术的系统评价
Health Technol Assess. 2001;5(5):1-186. doi: 10.3310/hta5050.
10
Patient preferences for the treatment of type 2 diabetes: a scoping review.患者对 2 型糖尿病治疗的偏好:综述
Pharmacoeconomics. 2013 Oct;31(10):877-92. doi: 10.1007/s40273-013-0089-7.

引用本文的文献

1
Public preferences for allocating health system resources in Canada: a systematic review.加拿大公众对卫生系统资源分配的偏好:一项系统综述。
Syst Rev. 2025 Jun 12;14(1):128. doi: 10.1186/s13643-025-02864-6.
2
Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity.基因组医学中的分布成本效益分析:解决健康公平问题的考量因素
Value Health. 2025 May 6. doi: 10.1016/j.jval.2025.04.2162.
3
Foresight approaches for future health shocks: integration into policy making and accompanying research priorities.
未来健康冲击的前瞻性方法:融入政策制定和伴随的研究重点。
BMJ. 2024 Oct 7;387:e078647. doi: 10.1136/bmj-2023-078647.
4
Val (EU) xit: do we need an international ISPOR value flower?瓦尔(欧盟)xit:我们需要一朵国际药物经济学与结果研究协会(ISPOR)价值之花吗? (注:这里“xit”不太明确准确含义,可能是特定语境下的特定指代,暂按原样翻译)
J Comp Eff Res. 2024 Sep;13(9):e240083. doi: 10.57264/cer-2024-0083. Epub 2024 Jul 19.